Amiloretic Tablets
PDF Leaflet Revision Date: 19 June 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Oedema and essential hypertension.
Dosage (summary)
One tablet daily for AMILORETIC; one to two tablets daily for AMILORETIC H.S.
Onset of Action / Duration
Onset: 2 hours, Duration: ~24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Lithium
- NSAIDs
- Potassium-sparing diuretics
Contraindications
- Hypersensitivity to components
- Severe renal disease
- Severe hepatic failure
- Hyperkalaemia
Common side effects
- Hyperkalaemia
- Hypotension
- Dizziness
- Nausea
Counselling Points
- Monitor for signs of electrolyte imbalance.
- Avoid potassium supplements without monitoring.
- Report any skin changes promptly.
Serious warnings
- Risk of hyperkalaemia
- Electrolyte imbalance
- Non-melanoma skin cancer risk
Important Disclaimer
The Amiloretic Tablets professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
